Background: Acute kidney injury (AKI) in hospitalized patients has significant implications in terms of morbidity and mortality, length of hospital stay and associated costs. To date, no interventions are proven to prevent the development of AKI but this is hampered in part by the lack of early recognition of patients at risk. We aimed to determine whether a simple system could be devised from both physiological and demographic data in order to identify individuals at increased risk from the development of inpatient AKI. Method: Our observational, population-based single-centred study took place in an 870-bed associated university hospital. All patients admitted to the acute medical admissions unit on the Worthing site of the Western Sussex Hospitals Trust during the study period were included. Results: Multivariate logistic regression analysis demonstrated that age, respiratory rate and disturbed consciousness together with a history of chronic kidney disease, diabetes mellitus, congestive cardiac failure and liver disease were associated with an increased risk of developing AKI within 7 days of admission. We derived a simple scoring system to identify acute medical patients at greater risk of developing AKI. Conclusions: The incidence of AKI complicating inpatient admissions remains high, however with the application of the derived AKI prediction score it is hoped that early recognition will translate to improved outcomes.

Keywords:
Acute kidney injury, Scoring systems, Acute medical admissions
1.
Chertow GM, Burdick E, Honour M, et al: Acute kidney injury, mortality, length of stay and costs in hospitalised patients. J Am Soc Nephrol 2005;16:3365-3370.
2.
Lassnigg A, Schmidlin D, Mouhieddine M, et al: Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 2004;15:1597-1605.
3.
Hoste EA, Kellum JA: Acute renal failure in the critically ill: impact on morbidity and mortality. Contrib Nephrol. Basel, Karger, 2004, vol 144, pp 1-11.
4.
White LE, Hassoun HT: Inflammatory mechanisms of organ crosstalk during ischemic acute kidney injury. Int J Nephrol 2012;2012:505197.
5.
Bellomo R, Ronco C, Kellum JA, et al: Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204-R212.
6.
Mehta RL, Kellum JA, Shah SV, et al: Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11:R31.
7.
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group: KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012;2:1-138.
8.
Uchino S, Kellum JA, Bellomo R, et al: Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators: Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005;294:813-818.
9.
Ostermann M, Chang RW: Correlation between the AKI classification and outcome. Crit Care 2008;12:R144.
10.
Coca SG, Yusuf B, Shlipak MG, et al: Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009;53:961-973.
11.
Stewart J, Findlay G, Smith N, et al: Adding insult to injury. A review of the care of patients who died in hospital with a primary diagnosis of acute kidney injury (acute renal failure). National Confidential Enquiry into Patient Outcome and Death. London, NCEPOD, 2009, pp 1-100.
12.
Selby NM, Crowley L, Fluck R, et al: Use of electronic results reporting to diagnose and monitor AKI in hospitalized patients. Clin J Am Soc Nephrol 2012;7:533-540.
13.
Kheterpal S, Tremper KK, Heung M, et al: Development and validation of an acute kidney injury risk index for patients undergoing general surgery. Anesthesiology 2009;110:505-515.
14.
Schneider DF, Dobrowolsky A, Shakir IA, et al: Predicting acute kidney injury among burn patients in the 21st century: a classification and regression tree analysis. J Burn Care Res 2012;33:242-251.
15.
Matheney ME, Miller RA, Ikizler TA, et al: Development of inpatient risk stratification models of acute kidney injury for use in electronic health records. Med Decis Making 2010;30:639-650.
16.
Wang HE, Muntner P, Chertow GM, et al: Acute kidney injury and mortality in hospitalized patients. Am J Nephrol 2012;35:349-355.
17.
Altman DG, Royston P: What do we mean by validating a prognostic model? Statist Med 2000;94:521-526.
18.
Fang Y, Ding X, Zhong Y, et al: Acute kidney injury in a Chinese hospitalized population. Blood Purif 2010;30:120-126.
19.
Meier P, Bonfils RM, Vogt B, et al: Referral patterns and outcomes in noncritically ill patients with hospital-acquired acute kidney injury. Clin J Am Soc Nephrol 2011;6:2215-2225.
20.
Girman CJ, Kou TD, Brodovicz K, et al: Risk of acute renal failure in patients with type 2 diabetes mellitus. Diabet Med 2012;29:614-621.
21.
Altamirano J, Fagundes C, Dominguez M, et al: Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis. Clin Gastroenterol Hepatol 2012;10:65-71.
22.
Tian J, Barrantes F, Amoateng-Adjepong Y, et al: Rapid reversal of acute kidney injury and hospital outcomes: a retrospective cohort study. Am J Kidney Dis 2009;53:974-981.
23.
Ostermann M, Phillips BJ, Forni LG: Biomarkers for the kidney: where are we now? Critical Care 2012;16:233.
24.
Katus HA, Remppis A, Scheffold T, et al: Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol 1991;67:1360-1367.
25.
Thygesen K, Alpert JS, White HD: Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction: Universal definition of myocardial infarction. Eur Heart J 2007;28:2525-2538.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.